Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents

The oncological use of cisplatin is hindered by its severe side effects and a very important resistance problem. To overcome these problems, scientists have attempted to design new generation transition-metal anticancer complexes. In this study, we present new complexes, ruthenium(II) [(η<sup>...

Full description

Bibliographic Details
Main Authors: Joanna Masternak, Agnieszka Gilewska, Iwona Łakomska, Barbara Barszcz, Katarzyna Kazimierczuk, Jerzy Sitkowski, Joanna Wietrzyk, Anna Kamecka, Magdalena Milczarek
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Materials
Subjects:
iridium(III) complexes
ruthenium half-sandwich
cytotoxicity
DNA interactions
Online Access:https://www.mdpi.com/1996-1944/13/16/3491

Similar Items

Similar Items